“Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up”, J of Skin, vol. 7, no. 2, p. s178, Mar. 2023, doi: 10.25251/skin.7.supp.178.